Accueil>>Signaling Pathways>> Endocrinology and Hormones>> Thyroid hormone Receptor>>1α-Hydroxy-3-epi-vitamin D3

1α-Hydroxy-3-epi-vitamin D3

Catalog No.GC62761

1α ; - L'hydroxy-3-épi-vitamine D3, un métabolite naturel de la 1alpha,25-dihydroxyvitamine D3, est un puissant suppresseur de la sécrétion de l'hormone parathyroÏdienne (PTH).

Products are for research use only. Not for human use. We do not sell to patients.

1α-Hydroxy-3-epi-vitamin D3 Chemical Structure

Cas No.: 58028-00-5

Taille Prix Stock Qté
1 mg
495,00 $US
En stock
5 mg
1 305,00 $US
En stock
10 mg
2 205,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

1α-Hydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone (PTH) secretion[1].

1 alpha, 25(OH)2D3 is an important negative regulator of parathyroid hormone (PTH) gene transcription[1]. In ROS 17/2.8 cells, 1α-OHD3 (10 μM) not only metabolized into 1αOH-3-epi-D3 and 1α,25(OH)2D3 but also 1α,25(OH)2-3-epi-D3[2].

[1]. A J Brown, et al. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion. J Cell Biochem. 1999 Apr 1;73(1):106-13.
[2]. Alex J Brown, et al. Isolation and identification of 1alpha-hydroxy-3-epi-vitamin D3, a potent suppressor of parathyroid hormone secretion. J Cell Biochem

Avis

Review for 1α-Hydroxy-3-epi-vitamin D3

Average Rating: 5 ★★★★★ (Based on Reviews and 8 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 1α-Hydroxy-3-epi-vitamin D3

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.